Westlake Village dermatology therapy startup Arcutis announced a $94.5 million capital raise Oct. 21 to fund Phase 3 clinical development for its topical plaque psoriasis treatment. The financing round was led by HBM Healthcare Investments and included funding from Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures and Goldman Sachs. Returning investors also contributed to the…
Print
Email
